Concerns that the Fed will have to wrestle with elevated inflation for a long time slowed this week’s rally
Given the prospect of a new governing coalition taking the reins in 2024, they should get to work on formulating a stance
The Competition Tribunal has approved the transaction without conditions
Mahumapelo is believed to be behind court challenge seeking to halt provincial conference
Group homes in on home deliveries trend and hopes to supply electricity to Eskom
Consumer finances crumble under the pressure of rising prices and interest rates, Unisa vulnerability report shows
Tight race unfolding between the leading presidential candidates
Debrief will determine whether All Blacks coach will remain in his job
Rushdie’s condition is not immediately known
Jerusalem — A fourth dose of Covid-19 vaccine boosts antibodies five-fold a week after the shot is administered, Israeli prime minister Naftali Bennett said on Tuesday, citing preliminary findings of an Israeli study.
"A week into the fourth dose we know to a higher degree of certainty that the fourth dose is safe," Bennett said at Sheba Medical Center, which is giving second booster shots in a trial among its staff amid a nationwide surge in Omicron variant infections.
"The second piece of news: we know that a week after administration of a fourth dose, we see a five-fold increase in the number of antibodies in the vaccinated person," he told reporters.
"This most likely means a significant increase against infection and … hospitalisation and [severe] symptoms," Bennett said in English.
Israel has played a leading role in studying the effects of Covid-19 vaccines, as the fastest country to roll out two-dose inoculations to a wide population a year ago and one of the first to give third shots as boosters. It is now administering fourth doses of the Pfizer-BioNTech vaccine to people over 60 years, health workers and immunocompromised patients.
Would you like to comment on this article? Register (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.